Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

ARKEMA R&D — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report (No Activity)

ARKEMA R&D

via STRATEGIC MARKETING INNOVATIONS

4th Quarter (Oct 1 - Dec 31) · 2022Posted Jan 19, 2023Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: ARKEMA R&D
Description: Chemical manufacturing
Location: Pennsylvania · United States of America

Registrant

Firm: STRATEGIC MARKETING INNOVATIONS
Description: Federal relations firm
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.